11.1 Acute Coronary Syndromes & Mechanical Complications of Myocardial Infarction

Acute Coronary Syndromes in the Intensive Care Unit

Acute coronary syndromes (ACS) encountered in the intensive care unit present unique diagnostic and therapeutic challenges. Critically ill patients may develop acute myocardial infarction (AMI) either as the primary reason for admission or as a secondary complication of severe systemic physiological derangements. Rapid risk stratification, differentiation between ST-elevation myocardial infarction (STEMI) and non-ST-elevation acute coronary syndromes (NSTE-ACS), and prompt therapeutic execution are critical determinants of survival.

Primary PCI Timing and Reperfusion Strategies

For patients presenting with STEMI or new left bundle branch block (LBBB) with clinical suspicion of acute transmural ischemia, immediate mechanical reperfusion is paramount:

• Primary Percutaneous Coronary Intervention (PCI): The standard of care when door-to-balloon time can be achieved within $\le 90\text{ minutes}$ at a PCI-capable center, or within $\le 120\text{ minutes}$ of first medical contact when transfer from a non-PCI center is required.
• Fibrinolytic Therapy: Indicated when transfer to a PCI-capable facility within $120\text{ minutes}$ is impossible and no absolute contraindications exist (e.g., prior intracranial hemorrhage, active internal bleeding, ischemic stroke within 3 months). Systemic fibrinolytics (tenecteplase, alteplase, or reteplase) should be administered within $\le 30\text{ minutes}$ of arrival ("door-to-needle" time), followed by routine transfer to a PCI center for emergent angiography.

In Non-ST-Elevation ACS (NSTEMI / Unstable Angina), management hinges on clinical risk stratification:

• Immediate Invasive Strategy ($< 2\text{ hours}$): Mandated for patients exhibiting hemodynamic instability or cardiogenic shock, recurrent or refractory angina despite medical therapy, life-threatening ventricular arrhythmias (sustained VT or VF), mechanical complications of MI, or acute decompensated heart failure with dynamic ST-T wave changes.
• Early Invasive Strategy ($< 24\text{ hours}$): Indicated for patients with established NSTEMI (elevated cardiac biomarkers), dynamic ischemic ECG changes, or a Global Registry of Acute Coronary Events (GRACE) risk score $> 140$.
• Selective Invasive (Conservative) Strategy: Reserved for low-risk patients (GRACE score $< 109$) without recurrent symptoms or objective ischemic signs, managed with non-invasive functional testing prior to discharge.

Anticoagulation and Dual Antiplatelet Therapy (DAPT)

Optimal pharmacological therapy balances ischemic prevention against life-threatening hemorrhage:

1. Aspirin: An initial loading dose of $162\text{--}325\text{ mg}$ (non-enteric coated, chewed for rapid buccal absorption) administered immediately, followed by daily maintenance therapy of $81\text{ mg}$ indefinitely.
2. Oral $\text{P2Y}_{12}$ Inhibitors:
   • Ticagrelor: Reversible, non-thienopyridine $\text{P2Y}_{12}$ inhibitor ($180\text{ mg}$ loading dose, followed by $90\text{ mg}$ BID). Demonstrates faster, more potent, and more consistent platelet inhibition than clopidogrel (PLATO trial).
   • Prasugrel: Irreversible thienopyridine prodrug ($60\text{ mg}$ loading dose, followed by $10\text{ mg}$ daily). Proven superior to clopidogrel in reducing ischemic events and stent thrombosis (TRITON-TIMI 38 trial). Strict Contraindications: Prior history of transient ischemic attack (TIA) or stroke. Generally not recommended in patients aged $\ge 75\text{ years}$ or body weight $< 60\text{ kg}$ due to heightened intracranial and fatal bleeding risks.
   • Clopidogrel: Thienopyridine ($600\text{ mg}$ loading dose, followed by $75\text{ mg}$ daily). Recommended when ticagrelor or prasugrel are contraindicated, in patients requiring concurrent oral anticoagulation ("triple/double therapy"), or when fibrinolysis is administered.
3. Intravenous Cangrelor: An ultra-short-acting, reversible intravenous $\text{P2Y}_{12}$ platelet inhibitor with an instantaneous onset of action and an elimination half-life of $3\text{--}6\text{ minutes}$ (plateau recovery within $1\text{--}2\text{ hours}$). Indicated in critically ill patients undergoing PCI who cannot absorb oral agents due to endotracheal intubation, cardiogenic shock with splanchnic hypoperfusion, therapeutic hypothermia, or when immediate surgical revascularization may be required.
4. Parenteral Anticoagulation:
   • Unfractionated Heparin (UFH): Standard weight-based bolus ($60\text{ units/kg}$, max $4000\text{ units}$) and continuous infusion ($12\text{ units/kg/hr}$, max $1000\text{ units/hr}$) titrated to maintain an activated partial thromboplastin time (aPTT) between $50\text{--}70\text{ seconds}$ (or activated clotting time [ACT] $200\text{--}250\text{ seconds}$ during PCI with GP IIb/IIIa inhibitors; $250\text{--}300\text{ seconds}$ without). UFH is favored in patients with severe renal failure (creatinine clearance $< 30\text{ mL/min}$) or impending cardiothoracic surgery.
   • Bivalirudin: Direct thrombin inhibitor; serves as an alternative to heparin plus glycoprotein IIb/IIIa inhibitors in patients with acute heparin-induced thrombocytopenia (HIT) or high bleeding risk.
   • Enoxaparin: Low-molecular-weight heparin ($1\text{ mg/kg}$ subcutaneous every 12 hours); requires dose reduction in renal impairment.
   • Fondaparinux: Factor Xa inhibitor; associated with lower bleeding in NSTEMI, but strictly contraindicated as the sole anticoagulant during PCI due to catheter-related thrombosis; must be co-administered with UFH if PCI is performed.

---

Type 1 vs. Type 2 Myocardial Infarction

The Fourth Universal Definition of Myocardial Infarction delineates distinct pathophysiological mechanisms that fundamentally alter ICU management:

• Type 1 Myocardial Infarction: Myocardial necrosis caused by spontaneous atherothrombotic coronary artery disease. A vulnerable fibroatheroma undergoes plaque rupture, ulceration, fissuring, or erosion, precipitating intraluminal thrombus formation in one or more coronary arteries with reduction of distal myocardial blood flow.
• Type 2 Myocardial Infarction: Myocardial injury with necrosis arising from a critical imbalance between myocardial oxygen supply and demand in the absence of acute atherothrombosis. In critically ill patients, common triggers include:
  • Supply Reduction: Severe hypoxemia (respiratory failure, severe ARDS), severe acute blood loss anemia, profound hypotension / shock (septic, hemorrhagic, distributive), vasospasm, coronary dissection, or microvascular dysfunction.
  • Demand Elevation: Severe sustained tachyarrhythmias (atrial fibrillation with RVR, sustained SVT/VT), hypertensive emergency, severe aortic valve stenosis, and intense endogenous or exogenous catecholamine surges.

Clinical Distinction and Critical Care Pitfalls

In the ICU, distinguishing Type 1 from Type 2 MI is vital:

• Biomarkers: Both entities present with elevated cardiac troponin with a characteristic rise and/or fall pattern above the 99th percentile upper reference limit. However, troponin elevation in septic shock is ubiquitous ($> 50\%$ of patients) and reflects supply-demand mismatch, microcirculatory thrombosis, or direct cytokine-mediated cardiomyocyte injury.
• Electrocardiography & Imaging: Type 1 MI classically exhibits focal regional ST elevations, ST depressions, T-wave inversions, and corresponding regional wall motion abnormalities (RWMAs) matching a single coronary anatomical distribution on echocardiography. Type 2 MI frequently displays non-focal subendocardial ischemia (diffuse ST depressions) or global ventricular hypokinesis without discrete territorial wall motion defects.
• Therapeutic Strategy: Patients with Type 1 MI require immediate revascularization (PCI or CABG), aggressive DAPT, and anticoagulation. In contrast, patients with Type 2 MI do not benefit from emergent coronary angiography or empiric DAPT; exposure to potent antithrombotics drastically increases bleeding morbidity without addressing the underlying pathology. Management of Type 2 MI requires identifying and correcting the underlying physiological trigger: restoring arterial oxygenation, transfusing red blood cells for severe anemia (targeting hemoglobin $\ge 7\text{--}8\text{ g/dL}$), titrating vasopressors to reverse shock, and achieving rate control for tachyarrhythmias.

---

Mechanical Complications of Acute Myocardial Infarction

Mechanical complications of AMI are catastrophic, life-threatening events that classically peak $3\text{ to }7\text{ days}$ post-infarction, corresponding to the period of maximal coagulative necrosis, neutrophilic infiltration, macrophage-mediated lysis, and collagen degradation prior to mature fibrotic scar organization. Although modern primary PCI has reduced their incidence to $< 1\%$, they carry an in-hospital mortality exceeding $50\%\text{ to }90\%$ if not rapidly diagnosed and surgically managed.

               MECHANICAL COMPLICATIONS OF AMI (DAYS 3-7)
                                    │
         ┌──────────────────────────┼──────────────────────────┐
         ▼                          ▼                          ▼
  VENTRICULAR SEPTAL         PAPILLARY MUSCLE           LEFT VENTRICULAR
    RUPTURE (VSR)             RUPTURE (PMR)            FREE WALL RUPTURE
  • Anterior/Inferior MI    • Inferior/Posterior MI    • Anterior/Lateral MI
  • Harsh holosystolic      • Posteromedial muscle     • Blowout: Tamponade, PEA
    murmur + thrill           (solitary PDA blood)     • Pseudoaneurysm:
  • O2 step-up >= 7%        • Acute flash pulmonary      narrow neck, high
    RA to RV/PA               edema, soft murmur         rupture risk
  • IABP / Impella bridge   • Giant v-waves on PCWP    • Emergency pericardiocentesis
  • Urgent surgical repair  • Emergent valve surgery     + open thoracotomy

1. Ventricular Septal Rupture (VSR)

Ventricular septal rupture results from transmural infarction involving either the anterior wall (occlusion of the left anterior descending [LAD] artery, causing apical septal defects) or the inferior/posterior wall (occlusion of the right coronary artery [RCA] or posterior descending artery [PDA], producing complex basal septal defects).

• Clinical Presentation: Sudden hemodynamic deterioration, rapidly progressive cardiogenic shock, and biventricular failure. Physical examination reveals a loud, harsh holosystolic murmur heard best along the left lower sternal border, accompanied by a palpable systolic thrill in $> 50\%$ of patients.
• Invasive Hemodynamic Confirmation: Pulmonary artery catheterization (PAC) demonstrates an oxygen saturation step-up $\ge 7\%\text{ to }10\%$ between the right atrium (mixed venous blood, typical $\text{SvO}_2 \approx 60\%$) and the right ventricle / pulmonary artery (elevated to $> 75\%\text{--}80\%$) due to left-to-right shunting of oxygenated left ventricular blood across the defect.
• Echocardiography: Transthoracic (TTE) or transesophageal (TEE) echocardiography with color Doppler directly visualizes the septal disruption, delineates defect size and anatomy (simple vs. serpentine/complex), demonstrates high-velocity left-to-right flow, and assesses right ventricular systolic strain.
• Critical Care Stabilization: The immediate objective is afterload reduction to decrease left-to-right shunt fraction and augment systemic forward flow. If blood pressure permits, titrate intravenous sodium nitroprusside. Mechanical circulatory support (MCS) is critical:
  • Intra-Aortic Balloon Pump (IABP): Provides counterpulsation, decreasing LV afterload during systole and enhancing coronary perfusion during diastole, diminishing left-to-right shunt volume.
  • Percutaneous Microaxial Flow Pump (Impella): Directly unloads the left ventricle, reduces LV end-diastolic volume and pressure, and minimizes shunt fraction.
• Definitive Management: Urgent surgical repair with a Dacron patch or percutaneous transcatheter closure in selected high-risk surgical candidates. Without intervention, 30-day mortality exceeds $90\%$.

2. Papillary Muscle Rupture (Acute Mitral Regurgitation)

Acute papillary muscle rupture is the most lethal cause of acute mitral regurgitation (MR) post-MI:

• Anatomical Vulnerability: The mitral valve apparatus contains two papillary muscles with starkly different arterial supplies:
  • Posteromedial Papillary Muscle: Receives a solitary blood supply from the posterior descending artery (PDA; branching from the RCA in $85\%$ of right-dominant individuals or the LCx in left-dominant systems). This single blood supply renders it exceptionally vulnerable to ischemic necrosis and complete rupture during acute inferior or posterior MI (responsible for $> 75\%$ of rupture cases).
  • Anterolateral Papillary Muscle: Has a dual, redundant blood supply from both the left anterior descending (LAD) diagonal branches and the left circumflex (LCx) obtuse marginal branches, making rupture exceedingly rare.
• Clinical Presentation: Abrupt, catastrophic clinical collapse characterized by acute flash pulmonary edema, extreme dyspnea, pink frothy sputum, tachypnea, and refractory cardiogenic shock.
• Physical Examination Trap: Unlike chronic mitral regurgitation, the systolic murmur of acute severe MR is frequently soft, early-systolic, or completely absent (silent MR). Because the normal-sized, non-compliant left atrium experiences a sudden massive volume overload, left atrial and left ventricular pressures rapidly equilibrate during mid-to-late systole, abolishing the late-systolic pressure gradient required to generate a loud, turbulent holosystolic murmur.
• Invasive Hemodynamics: PAC reveals marked elevation of pulmonary capillary wedge pressure (PCWP) with giant, tall $v$-waves (often peaking at $40\text{--}60\text{ mmHg}$), representing the forceful regurgitant jet ejecting backward into an unprepared, non-distensible left atrium during ventricular systole.
• Echocardiography: Bedside TTE or TEE reveals a hyperdynamic left ventricle with an underfilled end-systolic volume, a flail mitral leaflet (typically the P2/P3 scallop of the posterior leaflet), a mobile ruptured muscle head prolapsing into the left atrium during systole, and an eccentric, high-velocity regurgitant jet directed away from the flail leaflet.
• Management: Emergent surgical consultation for mitral valve replacement (preferred over repair due to extensive necrotic tissue) is mandatory. Temporizing medical stabilization requires immediate IABP placement (substantially reduces LV afterload, lowering regurgitant fraction and pulmonary venous congestion), cautious afterload reduction with nitroprusside if arterial pressure allows, inotropes (dobutamine), and urgent endotracheal intubation with positive-pressure ventilation.

3. Left Ventricular Free Wall Rupture (LVFWR)

Left ventricular free wall rupture occurs in approximately $1\%\text{ to }2\%$ of transmural infarctions, most commonly involving the anterior or lateral walls following occlusion of the LAD or LCx:

• Acute Blowout Rupture: A full-thickness tear through the necrotic myocardium into the pericardial space. Characterized by sudden, catastrophic hemopericardium, acute cardiac tamponade, electromechanical dissociation (pulseless electrical activity [PEA] arrest), and rapid death within minutes. Survival is rare and requires instantaneous bedside pericardiocentesis followed by emergency room thoracotomy / sternotomy.
• Subacute Rupture / Pseudoaneurysm: A contained rupture where the myocardial defect is sealed by adherent parietal pericardium, epicardial fibrous tissue, and organized mural thrombus, preventing immediate free hemorrhage:
  • Pseudoaneurysm (False Aneurysm): The wall of the cavity is composed entirely of pericardium and thrombus, without myocardial elements. It has a narrow neck connecting to the LV cavity (neck-to-cavity diameter ratio $< 0.5$). Because it lacks structural tensile strength, it possesses an exceptionally high risk of secondary catastrophic free rupture and requires urgent surgical resection.
  • True Left Ventricular Aneurysm: An area of thinned, scarred, dyskinetic or akinetic full-thickness myocardium resulting from late remodeling. It features a wide neck (neck-to-cavity ratio $> 0.5$). True aneurysms rarely rupture; complications include mural thrombus formation, systemic embolization, ventricular tachyarrhythmias, and heart failure.
• Clinical Presentation of Contained Rupture: Recurrent or persistent pleuritic chest pain, syncope, unexplained hypotension, elevated jugular venous pressure, pulsus paradoxus ($> 10\text{ mmHg}$ inspiratory drop in systolic arterial pressure), muffled heart sounds, and low-voltage QRS with electrical alternans on ECG.
• Critical Management: Immediate bedside echocardiography to confirm pericardial fluid with tamponade physiology (right ventricular diastolic collapse, right atrial late-diastolic collapse, exaggerated respiratory variation across the mitral and tricuspid valves). Emergent surgical repair with pericardial patch grafting; therapeutic pericardiocentesis is performed strictly as a life-saving temporizing bridge when cardiac arrest is imminent.

---

Right Ventricular Infarction

Right ventricular myocardial infarction complicates approximately $30\%\text{ to }50\%$ of acute inferior STEMIs, resulting from acute atherothrombotic occlusion of the proximal right coronary artery (RCA) upstream of the acute right ventricular marginal branches. In rare cases, it can result from occlusion of a dominant left circumflex artery supplying the inferior RV wall.

Pathophysiology and Ventricular Interdependence

The right ventricle is a thin-walled, compliant chamber designed to operate against low pulmonary vascular resistance (PVR). When extensive RV ischemia occurs, RV free-wall contractility drops precipitously, producing severe RV systolic failure and dilatation:

1. Preload Impairment of the Left Ventricle: The failing, stunned RV cannot generate sufficient transpulmonary forward flow to fill the left atrium and ventricle. As a result, left ventricular end-diastolic volume (LV preload) drops severely, precipitating an acute fall in stroke volume, low cardiac output, and profound systemic hypotension.
2. Ventricular Interdependence: Because the heart is constrained within the non-distensible fibrous pericardium, acute RV dilatation increases intrapericardial pressure. This forces the interventricular septum to shift leftward into the left ventricular cavity ("septal flattening" or reverse septal bowing), further impairing LV diastolic filling.

Clinical and Electrocardiographic Diagnosis

The classical clinical presentation features a hallmark physical triad:

• Systemic Hypotension: From severely diminished LV preload and forward cardiac output.
• Clear Lung Fields on Auscultation: Absence of pulmonary rales because left atrial and pulmonary capillary wedge pressures remain low or normal.
• Marked Jugular Venous Distension (JVD): High right atrial pressures manifesting as jugular distension, frequently with Kussmaul sign (a paradoxical inspiratory elevation or lack of fall in jugular venous pressure due to the inability of the non-compliant, stiff RV to accommodate augmented venous return during inspiration).

On the standard 12-lead ECG, inferior ST-elevation (leads II, III, aVF) is observed, with ST elevation in lead III typically greater than lead II. However, diagnosis requires right-sided precordial leads ($V_3R\text{--}V_6R$):

• ST elevation $\ge 1.0\text{ mm}$ in lead $V_4R$ (5th intercostal space, right midclavicular line) is the most useful single electrocardiographic marker of acute right ventricular infarction (sensitivity and specificity roughly $80\%$ to $90\%$ when recorded early).

Hemodynamic and Critical Care Management

Management of RV infarction is fundamentally distinct from isolated LV infarction:

1. Aggressive Preload Optimization: The ischemic RV functions as a passive conduit and requires elevated right-sided filling pressures ($CVP \approx 15\text{--}18\text{ mmHg}$) to generate transpulmonary forward flow. Administer rapid intravenous infusions of isotonic crystalloid ($500\text{--}1000\text{ mL}$ boluses, up to $2\text{--}3\text{ L}$) to restore cardiac output and arterial blood pressure.
2. Strict Avoidance of Preload-Reducing Agents: Nitrates (sublingual or IV nitroglycerin), morphine, diuretics, and ACE inhibitors are strictly contraindicated. Inadvertent administration of venodilators severely diminishes systemic venous return, precipitating immediate, catastrophic hemodynamic collapse.
3. Inotropic Support: If volume loading raises CVP above $15\text{--}18\text{ mmHg}$ without restoring mean arterial pressure (MAP $\ge 65\text{ mmHg}$) or cardiac index, initiate intravenous dobutamine ($2.5\text{--}10\mu\text{g/kg/min}$) to enhance RV contractility. If vasodilation worsens hypotension, co-administer norepinephrine to maintain coronary perfusion pressure.
4. Maintenance of Atrioventricular Synchrony: In the stiff, non-compliant right ventricle, synchronized right atrial contraction ("atrial kick") contributes up to $30\%\text{ to }40\%$ of RV filling. Atrioventricular dyssynchrony (e.g., atrial fibrillation or complete heart block) causes severe hemodynamic deterioration. High-grade AV block must be treated promptly with temporary sequential atrioventricular (AV) pacing, and atrial fibrillation requires immediate electrical cardioversion.
5. Emergent Reperfusion: Immediate primary PCI of the culprit proximal RCA is the definitive therapy, resulting in dramatic and rapid recovery of RV performance.